2017
DOI: 10.2174/1389201018666171115115112
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Fucoidan and Chemotherapeutic Agent Combinations on Malignant and Non-malignant Breast Cell Lines

Abstract: Fucoidan is an effective antitumor agent, either alone or in combination with cisplatin, doxorubicin and taxol in MCF-7 breast cancer cells. Drug combinations that discriminate between cancerous and non-cancerous cells afford a plausible and viable strategy of attaining therapeutic efficacy and avoiding possible toxicity and side effects. These findings suggest that fucoidan is a promising candidate for cancer combination therapies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
19
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 27 publications
(23 citation statements)
references
References 454 publications
(682 reference statements)
2
19
1
Order By: Relevance
“…Some studies reported that fucoidan exhibits several anticancer effects, including induction of apoptosis and inhibition of tumor-induced angiogenesis [128,129]. Effects on hepatocarcinoma and melanoma cancer have been reported, as well as in bladder, breast, colon, liver, lung, and prostate cells [130,131].…”
Section: Anticancer Activitymentioning
confidence: 99%
“…Some studies reported that fucoidan exhibits several anticancer effects, including induction of apoptosis and inhibition of tumor-induced angiogenesis [128,129]. Effects on hepatocarcinoma and melanoma cancer have been reported, as well as in bladder, breast, colon, liver, lung, and prostate cells [130,131].…”
Section: Anticancer Activitymentioning
confidence: 99%
“…Recent proven study in mainstream of MCF-7 breast cancer cells has been implied that the fucoidan can be a promising candidate for cancer therapy in combination of the cisplatin, doxorubicin and taxol [22]. Further, fucoidan induced apoptosis in PC-3 human prostate cancer cells has also been well documented [23].…”
Section: Introductionmentioning
confidence: 99%
“…They also reported that the combination of fucoidan and cisplatin was the most effective one [47]. The results have been confirmed by Abuddabus et al, who found that simultaneous incubation of cisplatin, doxorubicin or paclitaxel with fucoidan magnified therapeutic effects when compared to single agents [48]. A synergy between fucoidan and lapatinib has also been reported [49].…”
Section: Discussionmentioning
confidence: 78%